HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin-13 and transforming growth factor β synergise in the pathogenesis of human intestinal fistulae.

AbstractOBJECTIVE:
Epithelial to mesenchymal transition (EMT) seems to play an important role in the pathogenesis of fistulae, a common clinical complication of Crohn's disease (CD). TGFβ and interleukin-13 (IL-13) have been correlated with the onset of EMT-associated organ fibrosis and high levels of TGFβ have been shown in transitional cells (TCs) lining CD fistula tracts. This study investigated whether IL-13 could be involved in the pathogenesis of CD-associated fistulae.
DESIGN:
Protein or mRNA levels in HT29 intestinal epithelial cells (IECs) or colonic lamina propria fibroblasts (CLPFs) were studied by western blotting or real-time PCR. CLPFs were isolated from non-inflammatory disease controls or patients with CD with or without fistulae and IL-13 levels were analysed in surgically removed fistula specimens by immunohistochemistry.
RESULTS:
TGFβ induced IL-13 secretion in CLPFs from patients with fistulising CD. In fistula specimens high levels of IL-13 were detected in TCs covering fistula tracts. In HT29 IEC monolayers, IL-13 induced SLUG and β6-integrin mRNA, which are associated with cell invasion. HT29 spheroids completely disintegrated when treated with TGFβ for 7 days, whereas IL-13-treated spheroids did not show morphological changes. Here, TGFβ induced mRNA expression of SNAIL1 and IL-13, whereas IL-13 elevated SLUG and β6-integrin mRNA. An anti-IL-13 antibody was able to prevent IL-13-induced SLUG expression in HT29 IECs.
CONCLUSIONS:
TGFβ induces IL-13 expression and an EMT-like phenotype of IECs, while IL-13 promotes the expression of genes associated with cell invasion. These findings suggest that TGFβ and IL-13 play a synergistic role in the pathogenesis of fistulae and inhibition of IL-13 might represent a novel therapeutic approach for fistula treatment.
AuthorsMichael Scharl, Sandra Frei, Theresa Pesch, Silvia Kellermeier, Joba Arikkat, Pascal Frei, Michael Fried, Achim Weber, Ekkehard Jehle, Anne Rühl, Gerhard Rogler
JournalGut (Gut) Vol. 62 Issue 1 Pg. 63-72 (Jan 2013) ISSN: 1468-3288 [Electronic] England
PMID22287592 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Integrin beta Chains
  • Interleukin-13
  • SNAI1 protein, human
  • Snail Family Transcription Factors
  • Transcription Factors
  • Transforming Growth Factor beta
  • integrin beta6
Topics
  • Adult
  • Biomarkers (metabolism)
  • Blotting, Western
  • Case-Control Studies
  • Colitis, Ulcerative (metabolism)
  • Crohn Disease (complications, metabolism, pathology)
  • Female
  • Fibroblasts (metabolism, pathology)
  • HT29 Cells
  • Humans
  • Integrin beta Chains (metabolism)
  • Interleukin-13 (metabolism)
  • Intestinal Fistula (etiology, metabolism, pathology)
  • Intestinal Mucosa (metabolism, pathology)
  • Male
  • Middle Aged
  • Real-Time Polymerase Chain Reaction
  • Snail Family Transcription Factors
  • Transcription Factors (metabolism)
  • Transforming Growth Factor beta (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: